ASX:ALX

Stock Analysis Report

Atlas Arteria

Market Cap

AU$7.0b

Last Updated

2020/01/27 10:38 UTC

Data Sources

Company Financials +

Executive Summary

Atlas Arteria Limited invests in infrastructure and non-infrastructure assets.

Rewards

Earnings are forecast to grow 37.51% per year

Risk Analysis

Debt is not well covered by operating cash flow

Dividend of 3.62% is not well covered by earnings or forecast to be in the next 3 years

Shareholders have been substantially diluted in the past year

Large one-off items impacting financial results

+ 1 more risk

Snowflake Analysis

Reasonable growth potential with poor track record.

Similar Companies

Transurban Group

ASX:TCL

CIMIC Group

ASX:CIM

Share Price & News

How has Atlas Arteria's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: ALX has not had significant price volatility in the past 3 months.

Market Performance

7 Day Return

-2.3%

ALX

0.3%

AU Infrastructure

0.1%

AU Market

1 Year Return

22.4%

ALX

29.9%

AU Infrastructure

19.5%

AU Market

Return vs Industry: ALX underperformed the Australian Infrastructure industry which returned 32.3% over the past year.

Return vs Market: ALX exceeded the Australian Market which returned 19.4% over the past year.

Shareholder returns

ALXIndustryMarket
7 Day-2.3%0.3%0.1%
30 Day0.1%1.8%4.0%
90 Day-1.2%6.5%4.8%
1 Year29.5%22.4%35.2%29.9%24.9%19.5%
3 Year84.3%60.0%78.8%55.4%39.7%20.9%
5 Year238.1%170.2%120.6%76.0%59.0%23.1%

Price Volatility Vs. Market

How volatile is Atlas Arteria's share price compared to the market and industry in the last 5 years?

Simply Wall St News

1 week ago | Simply Wall St

What Kind Of Shareholder Appears On The Atlas Arteria Limited's (ASX:ALX) Shareholder Register?

1 month ago | Simply Wall St

Should You Use Atlas Arteria's (ASX:ALX) Statutory Earnings To Analyse It?

1 month ago | Simply Wall St

David Bartholomew Is The Independent Non Executive Director of Atlas Arteria Limited (ASX:ALX) And They Just Spent AU$80k On Shares

Valuation

Is Atlas Arteria undervalued compared to its fair value and its price relative to the market?

373.62x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: ALX (A$8.28) is trading above our estimate of fair value (A$5.37)

Significantly Below Fair Value: ALX is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: ALX is poor value based on its PE Ratio (388.1x) compared to the Infrastructure industry average (29.6x).

PE vs Market: ALX is poor value based on its PE Ratio (388.1x) compared to the Australian market (18.9x).

Price to Earnings Growth Ratio

PEG Ratio: ALX is poor value based on its PEG Ratio (10.3x)

Price to Book Ratio

PB vs Industry: ALX is overvalued based on its PB Ratio (2.6x) compared to the XO Infrastructure industry average (2.3x).

Next Steps

Future Growth

How is Atlas Arteria forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

39.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALX's forecast earnings growth (37.5% per year) is above the savings rate (1.1%).

Earnings vs Market: ALX's earnings (37.5% per year) are forecast to grow faster than the Australian market (9.6% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ALX's revenue (4.8% per year) is forecast to grow faster than the Australian market (3.8% per year).

High Growth Revenue: ALX's revenue (4.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ALX's Return on Equity is forecast to be low in 3 years time (9.9%).

Next Steps

Past Performance

How has Atlas Arteria performed over the past 5 years?

21.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ALX has a large one-off loss of A$51.5M impacting its June 30 2019 financial results.

Growing Profit Margin: ALX's current net profit margins (11.1%) are lower than last year (65.5%).

Past Earnings Growth Analysis

Earnings Trend: ALX has become profitable over the past 5 years, growing earnings by 21.5% per year.

Accelerating Growth: ALX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ALX had negative earnings growth (-77.5%) over the past year, making it difficult to compare to the Infrastructure industry average (-19.5%).

Return on Equity

High ROE: ALX's Return on Equity (-0.6%) is considered low.

Return on Assets

Return on Capital Employed

Next Steps

Financial Health

How is Atlas Arteria's financial position?

Financial Position Analysis

Short Term Liabilities: ALX's short term assets (A$153.5M) exceed its short term liabilities (A$86.0M).

Long Term Liabilities: ALX's short term assets (A$153.5M) do not cover its long term liabilities (A$2.2B).

Debt to Equity History and Analysis

Debt Level: ALX's debt to equity ratio (100.5%) is considered high.

Reducing Debt: Insufficient data to determine if ALX's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: ALX's debt is not well covered by operating cash flow (1.6%).

Interest Coverage: Insufficient data to determine if ALX's interest payments on its debt are well covered by EBIT.

Balance Sheet

Inventory Level: ALX has a low level of unsold assets or inventory.

Debt Coverage by Assets: ALX's debt is not covered by short term assets (assets are 0.1x debt).

Next Steps

Dividend

What is Atlas Arteria's current dividend yield, its reliability and sustainability?

3.76%

Current Dividend Yield

Dividend Yield vs Market

company3.8%marketbottom25%2.3%markettop25%5.5%industryaverage3.4%forecastin3Years4.9%

Current dividend yield vs market & industry

Notable Dividend: ALX's dividend (3.62%) is higher than the bottom 25% of dividend payers in the Australian market (2.34%).

High Dividend: ALX's dividend (3.62%) is low compared to the top 25% of dividend payers in the Australian market (5.47%).

Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, ALX has been paying a dividend for less than 10 years.

Growing Dividend: ALX's dividend payments have increased, but the company has only paid a dividend for 7 years.

Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (1265.7%), ALX's dividend payments are not well covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: ALX's dividends in 3 years are not forecast to be well covered by earnings (116.2% payout ratio).

Next Steps

Management

What is the CEO of Atlas Arteria's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure

CEO

Graeme Bevans (61yo)

0.8yrs

Tenure

0

Mr. Graeme Francis Bevans serves as Chief Executive Officer and Director at Atlas Arteria Limited since April 1, 2019. Mr. Bevans was a Partner at Alinda Capital Partners LLC since 2010. Mr. Bevans focused ...

Management Age and Tenure

0.8yrs

Average Tenure

Experienced Management: ALX's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Age and Tenure

1.3yrs

Average Tenure

59yo

Average Age

Experienced Board: ALX's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Insider Trading

Insider Buying: ALX insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

SellAU$39,090,18115 Jan 20
Yarra Funds Management Limited
EntityCompany
Shares4,902,389
Max PriceAU$7.97
BuyAU$62,214,35815 Jan 20
Yarra Funds Management Limited
EntityCompany
Shares8,751,818
Max PriceAU$7.11
BuyAU$6,56923 Dec 19
James Keyes
EntityIndividual
Shares952
Max PriceAU$6.90
BuyAU$29,43523 Dec 19
Derek Stapley
EntityIndividual
Shares4,266
Max PriceAU$6.90
BuyAU$114,63020 Dec 19
Nora Scheinkestel
EntityIndividual
Role
Chairman of the Board
Independent Non-Executive Chairman
Shares16,613
Max PriceAU$6.90
BuyAU$26,48220 Dec 19
Debra Goodin
EntityIndividual
Role
Member of the Board of Directors
Independent Non-Executive Director
Shares3,838
Max PriceAU$6.90
BuyAU$11,47520 Dec 19
David Bartholomew
EntityIndividual
Role
Member of the Board of Directors
Independent Non Executive Director
Shares1,663
Max PriceAU$6.90
BuyAU$22,34220 Dec 19
Jean-Georges Malcor
EntityIndividual
Role
Member of the Board of Directors
Independent Non-Executive Director
Shares3,238
Max PriceAU$6.90
BuyAU$9,19820 Dec 19
Fiona Beck
EntityIndividual
Shares1,333
Max PriceAU$6.90
BuyAU$100,16720 Dec 19
Graeme Bevans
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares14,517
Max PriceAU$6.90
BuyAU$163,118,88019 Dec 19
Lazard Asset Management LLC
EntityCompany
Shares22,775,791
Max PriceAU$8.40
SellAU$48,923,07019 Dec 19
Lazard Asset Management LLC
EntityCompany
Shares6,472,096
Max PriceAU$8.32
BuyAU$144,183,96117 Dec 19
Magellan Asset Management Limited
EntityCompany
Shares19,702,789
Max PriceAU$7.32
SellAU$4,987,01817 Dec 19
Magellan Asset Management Limited
EntityCompany
Shares620,432
Max PriceAU$8.04
BuyAU$17,73810 Dec 19
Jeffrey Conyers
EntityIndividual
Shares2,381
Max PriceAU$7.45
BuyAU$19,97402 Dec 19
Debra Goodin
EntityIndividual
Role
Member of the Board of Directors
Independent Non-Executive Director
Shares2,594
Max PriceAU$7.70
BuyAU$79,99402 Dec 19
David Bartholomew
EntityIndividual
Role
Member of the Board of Directors
Independent Non Executive Director
Shares10,113
Max PriceAU$7.91
BuyAU$54,574,55724 Oct 19
Lazard Asset Management LLC
EntityCompany
Shares6,883,679
Max PriceAU$8.30
BuyAU$63,744,24827 Sep 19
Lazard Asset Management LLC
EntityCompany
Shares7,652,699
Max PriceAU$8.60
BuyAU$55,49625 Sep 19
Fiona Beck
EntityIndividual
Shares7,000
Max PriceAU$7.93
BuyAU$147,90006 Sep 19
Derek Stapley
EntityIndividual
Shares17,400
Max PriceAU$8.50
BuyAU$49,90106 Sep 19
Nora Scheinkestel
EntityIndividual
Role
Chairman of the Board
Independent Non-Executive Chairman
Shares5,913
Max PriceAU$8.44
BuyAU$190,727,92728 Aug 19
Lazard Asset Management LLC
EntityCompany
Shares25,430,686
Max PriceAU$7.50
SellAU$121,600,66428 Aug 19
Lazard Asset Management LLC
EntityCompany
Shares17,416,357
Max PriceAU$6.98
BuyAU$43,54725 Aug 19
RREEF America L.L.C.
EntityCompany
Shares2,060,997
Max PriceAU$7.13
BuyAU$025 Aug 19
DBX Advisors LLC
EntityCompany
Shares10,021
Max PriceAU$6.79
SellAU$025 Aug 19
Deutsche Asset & Wealth Management
EntityCompany
Shares986,219
Max PriceAU$8.19
SellAU$025 Aug 19
Deutsche Bank, Private Banking and Investment Banking Investments
EntityCompany
Shares5,771,303
Max PriceAU$8.43
SellAU$48,63125 Aug 19
RREEF America L.L.C.
EntityCompany
Shares8,599,507
Max PriceAU$8.22
SellAU$025 Aug 19
DBX Advisors LLC
EntityCompany
Shares5,719
Max PriceAU$8.21
BuyAU$025 Aug 19
Deutsche Bank, Private Banking and Investment Banking Investments
EntityCompany
Shares5,306,030
Max PriceAU$8.44
BuyAU$4,326,96609 Aug 19
Yarra Funds Management Limited
EntityCompany
Shares559,382
Max PriceAU$7.74
BuyAU$015 Jul 19
Macquarie Group, Ltd., Banking & Securities Investments
EntityCompany
Shares1,273,573
Max PriceAU$8.26
BuyAU$015 Jul 19
Macquarie Investment Management Limited
EntityCompany
Shares25,726
Max PriceAU$8.12
SellAU$015 Jul 19
Macquarie Capital Investment Management LLC
EntityCompany
Shares1,286,004
Max PriceAU$7.97
SellAU$015 Jul 19
Macquarie Group, Ltd., Banking & Securities Investments
EntityCompany
Shares1,573,938
Max PriceAU$8.19
SellAU$015 Jul 19
Macquarie Investment Management Limited
EntityCompany
Shares25,726
Max PriceAU$8.12
BuyAU$280,97615 Jul 19
Macquarie Capital Investment Management LLC
EntityCompany
Shares60,631
Max PriceAU$7.99
SellAU$17,35515 Jul 19
Macquarie Investment Management Limited
EntityCompany
Shares2,268,978
Max PriceAU$11.41
BuyAU$39,35715 Jul 19
Macquarie Investment Management Limited
EntityCompany
Shares2,647,699
Max PriceAU$10.56
BuyAU$93,375,56809 Jul 19
Yarra Funds Management Limited
EntityCompany
Shares14,728,243
Max PriceAU$6.34
SellAU$153,246,62709 Jul 19
Yarra Funds Management Limited
EntityCompany
Shares22,327,528
Max PriceAU$6.86
BuyAU$54,483,03426 Jun 19
Magellan Asset Management Limited
EntityCompany
Shares7,834,606
Max PriceAU$6.95
SellAU$5,858,83126 Jun 19
Magellan Asset Management Limited
EntityCompany
Shares892,843
Max PriceAU$6.56
SellAU$030 May 19
FIL Limited
EntityCompany
Shares2,031,331
Max PriceAU$7.33
BuyAU$030 May 19
FIL Limited
EntityCompany
Shares294,750
Max PriceAU$7.26
SellAU$006 May 19
Macquarie Capital Investment Management LLC
EntityCompany
Shares2,087,842
Max PriceAU$7.26
SellAU$006 May 19
Macquarie Investment Management Limited
EntityCompany
Shares3,668,978
Max PriceAU$7.33
BuyAU$006 May 19
Macquarie Group, Ltd., Banking & Securities Investments
EntityCompany
Shares759,091
Max PriceAU$7.27
BuyAU$212,53606 May 19
Macquarie Investment Management Limited
EntityCompany
Shares3,768,453
Max PriceAU$9.97
SellAU$006 May 19
Macquarie Investment Management Limited
EntityCompany
Shares3,519,440
Max PriceAU$7.30
BuyAU$150,43106 May 19
Macquarie Capital Investment Management LLC
EntityCompany
Shares182,872
Max PriceAU$7.10
SellAU$006 May 19
Macquarie Group, Ltd., Banking & Securities Investments
EntityCompany
Shares369,025
Max PriceAU$7.32
BuyAU$006 May 19
Macquarie Investment Management Limited
EntityCompany
Shares3,519,440
Max PriceAU$7.30
SellAU$009 Apr 19
FIL Limited
EntityCompany
Shares9,788,638
Max PriceAU$7.30
BuyAU$009 Apr 19
FIL Limited
EntityCompany
Shares2,367,330
Max PriceAU$7.34
BuyAU$123,78502 Apr 19
Jean-Georges Malcor
EntityIndividual
Role
Member of the Board of Directors
Independent Non-Executive Director
Shares17,000
Max PriceAU$7.28
BuyAU$19,78207 Mar 19
Nora Scheinkestel
EntityIndividual
Role
Chairman of the Board
Independent Non-Executive Chairman
Shares2,867
Max PriceAU$6.90
BuyAU$99,59504 Mar 19
Debra Goodin
EntityIndividual
Role
Member of the Board of Directors
Independent Non-Executive Director
Shares14,476
Max PriceAU$6.88
BuyAU$60,23704 Mar 19
David Bartholomew
EntityIndividual
Role
Member of the Board of Directors
Independent Non Executive Director
Shares8,730
Max PriceAU$6.90
SellAU$018 Feb 19
Macquarie Investment Management Limited
EntityCompany
Shares3,581,939
Max PriceAU$6.95
SellAU$018 Feb 19
Macquarie Investment Management Limited
EntityCompany
Shares3,149,568
Max PriceAU$7.00
BuyAU$152,73318 Feb 19
Macquarie Capital Investment Management LLC
EntityCompany
Shares835,530
Max PriceAU$6.98
BuyAU$018 Feb 19
Macquarie Investment Management Limited
EntityCompany
Shares2,778,258
Max PriceAU$7.00
SellAU$79,96018 Feb 19
Macquarie Capital Investment Management LLC
EntityCompany
Shares97,603
Max PriceAU$6.85
BuyAU$018 Feb 19
Macquarie Investment Management Limited
EntityCompany
Shares3,581,939
Max PriceAU$6.95

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 82.9%.

Management Team

  • Graeme Bevans (61yo)

    CEO & Director

    • Tenure: 0.8yrs

  • Clayton McCormack

    Company Secretary & General Counsel

    • Tenure: 0.8yrs

  • Nadine Lennie (46yo)

    Chief Financial Officer

    • Tenure: 0.8yrs

  • Navleen Prasad

    Public Affairs Manager

    • Phillipa Chen

      Head of Investor Relations

      • Vincent Portal-Barrault

        Chief Operating Officer

        • Tenure: 0.8yrs

      Board Members

      • NL Scheinkestel (59yo)

        Independent Non-Executive Chairman

        • Tenure: 4.8yrs
        • Compensation: AU$210.00k

      • Graeme Bevans (61yo)

        CEO & Director

        • Tenure: 0.8yrs

      • Jean-Georges Malcor (63yo)

        Independent Non-Executive Director

        • Tenure: 1.2yrs
        • Compensation: AU$24.58k

      • David Bartholomew (58yo)

        Independent Non Executive Director

        • Tenure: 1.3yrs
        • Compensation: AU$35.42k

      • Debbie Goodin (52yo)

        Independent Non-Executive Director

        • Tenure: 2.3yrs
        • Compensation: AU$178.13k

      Company Information

      Atlas Arteria Limited's company bio, employee growth, exchange listings and data sources

      Key Information

      • Name: Atlas Arteria Limited
      • Ticker: ALX
      • Exchange: ASX
      • Founded: 2009
      • Industry: Highways and Railtracks
      • Sector: Transportation
      • Market Cap: AU$7.006b
      • Shares outstanding: 879.02m
      • Website: https://www.atlasarteria.com

      Location

      • Atlas Arteria Limited
      • 50 Martin Place
      • Level 7
      • Sydney
      • New South Wales
      • 2000
      • Australia

      Listings

      TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
      ALXASX (Australian Securities Exchange)YesStapled SecuritiesAUAUDJan 2010
      M82DB (Deutsche Boerse AG)YesStapled SecuritiesDEEURJan 2010
      MAQA.FOTCPK (Pink Sheets LLC)YesStapled SecuritiesUSUSDJan 2010
      ALXCHIA (Chi-X Australia)YesStapled SecuritiesAUAUDJan 2010

      Biography

      Atlas Arteria Limited invests in infrastructure and non-infrastructure assets. It holds a 13.4% interest in TRIP II, the concessionaire for Dulles Greenway toll road located in northern Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Sydney, Australia. 

      Company Analysis and Financial Data Status

      All financial data provided by Standard & Poor's Capital IQ.
      DataLast Updated (UTC time)
      Company Analysis2020/01/27 10:38
      End of Day Share Price2020/01/24 00:00
      Earnings2019/06/30
      Annual Earnings2018/12/31


      Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.